BEUMONT MARIA GLORIA,HERDINIUS STEFAN RIKARD,PICCHIO GASTON RAFAEL,POLO RAMON,KAUFFMAN ROBERT S,ADIWIJAYA BAMBANG S,GARG VARUN
申请号：
IN33/MUMNP/2011
公开号：
IN2011MN00033A
申请日:
2011.01.07
申请国别(地区):
IN
年份:
2014
代理人:
摘要：
This invention relates to the use of specific dosing regimens of telaprevir in combination with peg-IFN and RBV in the treatment of HCV patients, wherein the treatment comprises (a) a lead-in phase of administering to the subject pegylated interferon and ribavirin, and (b) a treatment phase of administering to the subject a combination of telaprevir, pegylated interferon and ribavirin.
